CHA
MBIO icon

Carmichael Hill & Associates’s Mustang Bio MBIO Stock Holding History

Carmichael Hill & Associates’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$35 – 785
2024
Q1 		$35 Hold
1
– – ﹤0.01% 761
2023
Q4 		$45 Hold
1
– – ﹤0.01% 787
2023
Q3 		$69 Hold
1
– – ﹤0.01% 783
2023
Q2 		$205 Buy
+1
New +$251 ﹤0.01% 772
2023
Q1 		– Sell
-1
Closed -$197 – 799
2022
Q4 		$197 Hold
1
– – ﹤0.01% 766
2022
Q3 		$0 Hold
1
– – ﹤0.01% 847
2022
Q2 		$0 Hold
1
– – ﹤0.01% 851
2022
Q1 		$1K Hold
1
– – ﹤0.01% 774
2021
Q4 		$1K Hold
1
– – ﹤0.01% 783
2021
Q3 		$1K Buy
+1
New +$2.15K ﹤0.01% 775

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Carmichael Hill & Associates's MBIO Position: Q2 2024 in Review

Carmichael Hill & Associates sold out of Mustang Bio (MBIO) in Q2 2024, closing a stake of 1 share — an estimated $35 sold.

Carmichael Hill & Associates first reported a position in MBIO in Q3 2021 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 28 funds tracked by Wall St. Rank hold MBIO as of Q2 2024.

  • Carmichael Hill & Associates reported no remaining Mustang Bio position as of Q2 2024 after selling out during the quarter.
  • Carmichael Hill & Associates sold 1 Mustang Bio share in Q2 2024, an estimated $35.
  • Carmichael Hill & Associates first reported a position in Mustang Bio in Q3 2021 and held it in 10 quarters.
  • Carmichael Hill & Associates's Mustang Bio position peaked at $1K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2024.

Based on Carmichael Hill & Associates's 13F filing for Q2 2024, filed 2 Aug 2024.